Infectious Disease Control
2nd Global Forum of People's Organizations on Hansen's Disease Focuses on Capacity Building to Promote Dignity of Those Affected by the Disease
TOKYO, Nov. 3, 2022 /PRNewswire/ -- The 2nd Global Forum of People's Organizations on Hansen's Disease takes place inHyderabad, India, from November 6 to 8, 2022. Organized by Sasakawa Leprosy (Hansen's Disease) Initiative as part of its "Don't Forget Leprosy" campaign, the forum is being held a...
2022-11-03 21:00
2408
Ascletis Announces U.S. IND Filing of Oral 3CLpro Inhibitor ASC11 for COVID-19
-- ASC11 is an in-house discovered oral small molecule drug candidate, targeting 3-chymotrypsin like protease (3CLpro) -- In antiviral cellular assays with infectious SARS-CoV-2, ASC11 demonstrated higher potency against SARS-CoV-2 than other 3CLpro inhibitors including Nirmatrelvir, S-217622, P...
2022-11-02 08:10
3519
GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis
SINGAPORE, Nov. 1, 2022 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supportedChulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production a...
2022-11-01 11:39
5800
Yiling Pharmaceutical Exhibiting its Innovative TCM Products during CHEXPO Macau 2022
SHIJIAZHUANG, China, Oct. 26, 2022 /PRNewswire/ -- CHEXPO Macau 2022 was officially opened onOctober 20, 2022. As one of the top 10 TCM enterprises in China, Yiling Pharmaceutical exhibited a number of its patented TCM and health products during the expo. As an international and frontier city of ...
2022-10-26 16:52
2990
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...
2022-10-25 20:00
3386
U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster for Adults
GAITHERSBURG, Md., Oct. 22, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) has received eme...
2022-10-22 03:25
9061
Brii Biosciences Presents Promising Clinical Data to Support Ongoing Development of Novel HIV Therapeutic Candidates at IDWeek 2022
* Findings from two Phase 1 studies show both BRII-732 and BRII-778 are safe and well-tolerated * Results indicate potential for oral once-weekly, long-acting combination therapy for HIV infection, supporting continued clinical development * Additional data presented by Brii's licensing part...
2022-10-19 20:00
3517
The Grand Hamdan Award goes to two scientists in Australia
DUBAI, UAE, Oct. 19, 2022 /PRNewswire/ -- According to an official announcement
made recently inDubai, Prof. Ian Hector Frazer and the Late Dr. Jian Zhou are
the winners of the Grand Hamdan Award for the topic of – Infectious Diseases in
the Award's 12th term (2021-2022).
2022-10-19 04:05
2260
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) - the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products.
SINGAPORE, Oct. 17, 2022 /PRNewswire/ -- GenScript ProBio (a global one-stop CDMO from GenScript Group) today announced a strategic collaboration with Hibiocy Co. Ltd., a private corporation based inBangkok, Thailand, to accelerate a respiratory-care medical device, COVITRAP™ which contains human...
2022-10-17 23:56
7053
World Health Summit kicks off with German Chancellor Scholz, numerous Government Officials, WHO Director-General Tedros
Global health in focus BERLIN, Oct. 17, 2022 /PRNewswire/ -- The World Health Summit 2022, the world's leading meeting for global health, began on Sunday morning inBerlin. For the first time it is co-hosted by the World Health Organization (WHO). Among the central topics are climate change and h...
2022-10-17 10:24
1781
With New Commitment, Gates Foundation Joins Call to Help End Polio
BERLIN, Oct. 17, 2022 /PRNewswire/ -- Today at the World Health Summit, the Bill & Melinda Gates Foundation announced it will commit$1.2 billion to support efforts to end all forms of polio globally. The announcement was made ahead of a key pledging moment that will be co-hosted by Germany and the...
2022-10-17 01:30
3133
Gilead and the IAS start second year of partnership to honor champions of stigma-free HIV care services in Asia and Latin America
SINGAPORE, Oct. 13, 2022 /PRNewswire/ -- Gilead Sciences, Inc. and IAS – the International AIDS Society – have renewed their Me and My Healthcare Provider partnership to expand the campaign inBrazil, Hong Kong, Mexico, South Korea and Taiwan. The collaborative partnership, now entering its second...
2022-10-13 11:10
2830
Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants
* Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 * Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consist...
2022-10-12 21:35
3926
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression
* Data demonstrated that a single administration of BRII-296 at 600 mg delivered a favorable pharmacokinetic profile and is safe and well-tolerated in healthy subjects * Findings suggest BRII-296 has potential to provide a safe and effective, one-time injectable treatment option to people wit...
2022-09-26 20:00
3682
Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals
First in-person Goalkeepers event since 2019 convenes global changemakers to highlight the urgency of achieving a more equitable world by 2030 NEW YORK, Sept. 22, 2022 /PRNewswire/ -- During United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanth...
2022-09-22 06:36
3118
MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19
LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Lo...
2022-09-21 17:13
3851
Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections
* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...
2022-09-20 17:00
4254
Apex Circuit (Thailand) Co., Ltd. Awarded at the Asia Responsible Enterprise Awards 2022 for 'Vaccine 100' under Health Promotion Category
SINGAPORE, Sept. 15, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initia...
2022-09-15 16:48
3023
GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS
-- In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally -- -- Gilead also ranks first among peers in Asia by patient groups in this region -- HONG KONG, Sept. 15, 2022 /PRNewswire/ -- Gilead Sciences...
2022-09-15 10:00
2666
TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro
Adds further support for its broad-spectrum mechanism of action following other recent TBI, ALS and tropical virus studies VIKEN, Sweden, Sept. 13, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study evaluating the ability of the company's lead drug candid...
2022-09-13 16:08
2240
Week's Top Stories
Most Reposted
Visa redefines its role in travel with the global expansion of Visa Destinations
[Picked up by 336 media titles]
2026-06-30 10:00Sustainable Tourism Academy Celebrates 3,000-User Milestone in First Year with ASEAN Expansion and New Language Support
[Picked up by 323 media titles]
2026-06-29 12:41
Agoda rolls out suite of new features focused on real-time updates and smarter trip planning
[Picked up by 321 media titles]
2026-07-01 10:00
On-us Brings Real-Time Smart E-Vouchers to Google Wallet, Giving Marketers a Live Read on Customer Behavior
[Picked up by 319 media titles]
2026-06-30 11:00
Avnet Brings Ecosystem Together to Scale Edge AI in Singapore
[Picked up by 305 media titles]
2026-06-30 09:00Most Read
JINRO, the World's No. 1 Soju Brand, Partners with V of BTS
2026-07-03 08:00
8656
/UPDATE TO VIDEO -- New York Stock Exchange/
2026-07-01 01:36
6304
Farmmi, Inc. Announces Launch of Proposed Public Offering
2026-06-27 08:01
5339
NYSE Content Update: Mobility Global Marks First Day as Public Company
2026-07-01 21:22
5269
